UAE approves highly effective new treatment for coronavirus - GulfToday

UAE approves highly effective new treatment for coronavirus


Photo used for illustrative purpose.

Gulf Today, Staff Reporter

The UAE Ministry of Health and Prevention (MoHAP) has approved the emergency use of a highly effective new treatment for COVID-19, becoming the first country in the world to both licence and enable immediate patient use.

Endorsed by the US Food and Drug Administration, the new treatment, from globally-leading healthcare company, GSK, "Sotrovimab (Vir-7831" offers the prospect of reducing hospitalisation for more than 24 hours and fatalities by as much as 85% when administered to patients as an early treatment for COVID-19.

The UAE has authorised the emergency use of Sotrovimab, a monoclonal antibody, for the treatment of patients aged 12 years or older with mild to moderate COVID-19 disease who are at risk of progression to hospitalisation or death.

In pre-clinical studies, Sotrovimab has demonstrated effectiveness as monotherapy against widely circulating variants of the disease. 

Related articles